Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Forma Therapeutics, Inc.

Clinical trials sponsored by Forma Therapeutics, Inc., explained in plain language.

Now part of Novo Nordisk A/S NVO NYSE

A biopharmaceutical company developing therapies for rare diseases and cancer, acquired by Novo Nordisk.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 2 Terminated 2

New pill could slash sickle cell pain crises

Disease control Ongoing

This large Phase 3 trial is testing an oral drug called etavopivat in 450 people with sickle cell disease. The goal is to see if taking a pill once daily can raise hemoglobin levels and reduce the number of painful vaso-occlusive crises compared to a placebo. Participants must ha…

Phase: PHASE3 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC